Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated

Jesús Saavedra-Lozano1, José T Ramos, Francisco Sanz

  • 1UT Southwestern Medical Center, Dallas, TX, USA. jsaavedra.hflr@salud.madrid.org

Insights

High-dose abacavir (ABC) combined with other antiretroviral (ARV) agents is safe and effective for treating HIV-associated encephalopathy (HIV-AE) in children, improving virologic, immunologic, and neuropsychological outcomes.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Pharmacology

Background:

  • HIV-associated encephalopathy (HIV-AE) is a severe neurological condition in children with Human Immunodeficiency Virus (HIV).
  • The efficacy of antiretroviral (ARV) agents with good cerebrospinal fluid (CSF) penetration for HIV-AE is not well-defined.
  • Abacavir (ABC) demonstrates good CSF penetration and has shown promise in adults with HIV dementia.

Purpose of the Study:

  • To evaluate the safety and efficacy of an ARV regimen including high-dose abacavir (ABC) in children diagnosed with HIV-AE.
  • To assess virologic, immunologic, and neuropsychological responses to the high-dose ABC regimen.

Main Methods:

  • The study enrolled abacavir-naive children aged 3 months to 18 years with HIV-AE and virologic failure.
  • Participants received a high-dose abacavir-containing ARV regimen.
  • Safety, virologic load, CD4 counts, and neuropsychological function were assessed over 48 weeks.

Main Results:

  • 14 out of 17 enrolled children completed 48 weeks of therapy with good overall tolerability.
  • Significant reductions in HIV RNA levels were observed in both plasma and CSF.
  • Mean increases in CD4 cell count and CD4% were noted, along with reduced soluble tumor necrosis factor receptor II concentrations.
  • Children under 6 years old showed significant neuropsychological improvement.

Conclusions:

  • Highly active antiretroviral therapy (HAART) including high-dose abacavir (ABC) is safe and effective in children with HIV-AE.
  • The regimen demonstrated significant clinical, immunologic, and virologic benefits at 48 weeks.
  • Younger children (under 6 years) experienced notable neuropsychological improvements, highlighting the regimen's impact on cognitive function.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...